Terug
85
Ook genoteerd als
HMDCF
OTC
Dagbereik
€ 13,84
€ 14,12
52-Weeksbereik
€ 11,51
€ 19,50
Volume
16.136
50D / 200D Gem.
€ 14,74
/
€ 15,33
Vorige Slotkoers
€ 14,00
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 5,6 | 0,3 |
| P/B | 2,1 | 2,9 |
| ROE % | 45,9 | 3,7 |
| Net Margin % | 83,3 | 3,8 |
| Rev Growth 5Y % | 11,5 | 10,0 |
| D/E | 0,1 | 0,2 |
Koersdoel Analisten
Hold
€ 17,50
+23.9%
Forward K/W
44,1
Forward WPA
€ 0,32
WPA Groei (sch.)
+0,0%
Omzet Sch.
640 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 1,17
€ 1,09 – € 1,35
|
1,2 B | 1 |
| FY2029 |
€ 0,88
€ 0,82 – € 1,02
|
1,1 B | 1 |
| FY2028 |
€ 0,60
€ 0,56 – € 0,69
|
840 M | 1 |
Belangrijkste Punten
Revenue grew 11,48% annually over 5 years — strong growth
Earnings grew 1114,23% over the past year
ROE of 45,86% indicates high profitability
Net margin of 83,30% shows strong profitability
Debt/Equity of 0,08 — conservative balance sheet
Negative free cash flow of -79,01M
Groei
Revenue Growth (5Y)
11,48%
Revenue (1Y)-12,73%
Earnings (1Y)1114,23%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
45,86%
ROIC-3,07%
Net Margin83,30%
Op. Margin-9,95%
Veiligheid
Debt / Equity
0,08
Current Ratio4,96
Interest Coverage-19,05
Waardering
P/E Ratio
5,57
P/B Ratio2,06
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -12,73% | Revenue Growth (3Y) | -18,99% |
| Earnings Growth (1Y) | 1114,23% | Earnings Growth (3Y) | 113,21% |
| Revenue Growth (5Y) | 11,48% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 549,96M | Net Income (TTM) | 458,12M |
| ROE | 45,86% | ROA | 26,13% |
| Gross Margin | 38,68% | Operating Margin | -9,95% |
| Net Margin | 83,30% | Free Cash Flow (TTM) | -79,01M |
| ROIC | -3,07% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,08 | Current Ratio | 4,96 |
| Interest Coverage | -19,05 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 5,57 | P/B Ratio | 2,06 |
| P/S Ratio | 4,64 | PEG Ratio | 0,00 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 2,55B | Enterprise Value | 2,58B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 549,96M | 630,20M | 838,00M | 426,41M | 356,13M |
| Net Income | 458,12M | 37,73M | 100,78M | -360,84M | -194,65M |
| EPS (Diluted) | 2,60 | 0,22 | 0,60 | -2,15 | -1,25 |
| Gross Profit | 212,72M | 281,32M | 453,55M | 115,31M | 97,89M |
| Operating Income | -54,73M | -43,71M | 18,38M | -409,77M | -344,29M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,75B | 1,27B | 1,28B | 1,03B | 1,37B |
| Total Liabilities | 501,84M | 502,34M | 536,39M | 392,58M | 333,15M |
| Shareholders' Equity | 1,24B | 759,93M | 730,54M | 610,37M | 986,89M |
| Total Debt | 97,89M | 89,82M | 86,13M | 27,01M | 38,98M |
| Cash & Equivalents | 71,33M | 153,96M | 283,59M | 313,28M | 377,54M |
| Current Assets | 1,57B | 1,07B | 1,10B | 839,89M | 1,21B |
| Current Liabilities | 315,78M | 376,56M | 403,03M | 353,90M | 311,66M |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#20 of 669
Recente Activiteit
Ingestapt
Contrarian Investing (David Dreman)
Mar 24, 2026